Forward Pharma A/S Announces Termination of its American Depositary Receipts (“ADR”) Facility

COPENHAGEN, Denmark, Jan. 08, 2024 (GLOBE NEWSWIRE) -- Forward Pharma A/S (“Forward” or the “Company”) today announced that its Board of Directors has approved a termination of the Deposit Agreement, dated October 14, 2014, among Forward Pharma A/S (Forward Pharma), the Depositary Bank of New York Mellon, and Owners and Holders of ADRs.

As a result, the existing ADR facility will be terminated effective at 5:00 PM (Eastern Time) on February 5, 2024.

Kindly see additional information at the website of the Depositary Bank of New York Mellon (https://www.adrbnymellon.com/files/ad1136444.pdf).

Forward Pharma A/S Investor Relations Contact:
Investor Relations
investors@forward-pharma.com

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

You just read:

Forward Pharma A/S Announces Termination of its American Depositary Receipts (“ADR”) Facility

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...

EIN Presswire's priority is author transparency. We do our best to weed out false and misleading content. The content above is the sole responsibility of the author who makes it available. If you have any complaints, kindly contact the author above.